Which ETFs hold IAM? Iambic Therapeutics Inc is held by 1 fund tracked by ETFpeek.
Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally. It offers products, such as IAM-1363, a selective HER2 inhibitor; IAM-K1, a KIF18A inhibitor; IAM217 (a KIF18A inhibitor) and IAM-C1, a CDK2/4 inhibitor; and services, including drug discovery platform and molecular superintelligence platform which includes technologies, such as Enchant and NeuralPLexer to design and develop small molecule therapeutics. Iambic Therapeutics, Inc. was formerly known as Entos, Inc. and changed its name to Iambic Therapeutics, Inc. in May 2023. The company was incorporated in 2019 and is based in San Diego, California.
| Date | Person | Action | Plan | Shares | Value | Score |
|---|---|---|---|---|---|---|
| 14 Oct 2026 | Frederick R Manby Director / Other | BUY | Vested (RSU) | 925,400 2 tranches | — | 30 |
| 14 Oct 2026 | Peter A Olson Director / Other | BUY | Vested (RSU) | 136,400 2 tranches | — | 30 |
| 14 Oct 2026 | R Jacob Vogelstein Director / Other | BUY | Vested (RSU) | 20,300 | — | 30 |
| 14 Oct 2026 | Evan Lockwood Rachlin Director / Other | BUY | Vested (RSU) | 20,300 | — | 30 |
| 14 Oct 2026 | Thomas F. Miller Director / Other | BUY | Vested (RSU) | 925,400 2 tranches | — | 30 |
| 14 Oct 2026 | Neil Josephson Director / Other | BUY | Vested (RSU) | 216,900 2 tranches | — | 30 |
| 14 Oct 2026 | Michael Secora Director / Other | BUY | Vested (RSU) | 198,700 2 tranches | — | 30 |
| 14 Oct 2026 | Shalini Sharp Director / Other | BUY | Vested (RSU) | 20,300 | — | 30 |
| 14 Oct 2026 | Mary Tagliaferri Director / Other | BUY | Vested (RSU) | 20,300 | — | 30 |
| 14 Oct 2026 | Kurt Von Emster Director / Other | BUY | Vested (RSU) | 20,300 | — | 30 |
| 14 Oct 2026 | William H Rastetter Director / Other | BUY | Vested (RSU) | 40,600 | — | 30 |
| Date | Fund | Direction | Shares Changed | % Δ ETF | % Δ Position |
|---|---|---|---|---|---|
| 23 Oct 2026 | ARKG | BUYAdded | +6,601 | -0.03% | 0.50% |
| 22 Oct 2026 | ARKG | BUYAdded | +18,944 | -0.02% | 1.45% |
| 21 Oct 2026 | ARKG | BUYAdded | +101,304 | +0.03% | 8.25% |
| 20 Oct 2026 | ARKG | BUYNew position | +1,254,689 | +0.98% | 100.00% |
| No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal. | |||||